Literature DB >> 23611369

Regional differences regarding risk of developing rheumatoid arthritis in Stockholm County, Sweden: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study.

H Källberg1, V Vieira, M Holmqvist, J E Hart, K H Costenbader, C Bengtsson, L Klareskog, E W Karlson, L Alfredsson.   

Abstract

OBJECTIVES: Rheumatoid arthritis (RA) is a complex disease that is associated with genetic and environmental factors. We have investigated geospatial variation in the risk of developing RA within Stockholm County, Sweden, with respect to established environmental risk factors for RA, as well as serologically defined subgroups of RA.
METHOD: Information regarding geographical location for 1432 cases and 2529 controls from the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study, living in Stockholm County at RA symptom onset, or matched date for controls, was used to estimate geospatial variation in risk. We used generalized additive models (GAMs) to create a risk surface, calculate odds ratios (ORs), and adjust for potential confounding by smoking, education level, and RA within family. We performed a stratified analysis based on the presence/absence of anti-citrullinated peptide antibodies (ACPA).
RESULTS: We found significant spatial variation in the odds of developing RA in Stockholm County. After adjustment for smoking, education level, and family history of RA, this geospatial variation remained. The stratified analysis showed areas with higher ORs for ACPA-positive RA and ACPA-negative RA, after adjusting for smoking, education level, and having a family history of RA. Living in the city of Stockholm was associated with decreased risk of RA.
CONCLUSIONS: The risk of developing RA in Stockholm County is not distributed evenly and there are areas of increased risk that could not be explained by known factors. Further investigations of local exposures or social factors are warranted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23611369      PMCID: PMC3815679          DOI: 10.3109/03009742.2013.769062

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  22 in total

1.  The impact of social capital on changes in smoking behaviour: a longitudinal cohort study.

Authors:  Giuseppe N Giordano; Martin Lindström
Journal:  Eur J Public Health       Date:  2010-06-21       Impact factor: 3.367

2.  The Swedish Multi-generation Register.

Authors:  Anders Ekbom
Journal:  Methods Mol Biol       Date:  2011

Review 3.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

Review 4.  Prevention of autoimmune rheumatic disease: state of the art and future perspectives.

Authors:  Lars Klareskog; Peter K Gregersen; Tom W J Huizinga
Journal:  Ann Rheum Dis       Date:  2010-12       Impact factor: 19.103

5.  The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigens.

Authors:  Annemiek Willemze; Diane van der Woude; Wendimagegn Ghidey; E W Nivine Levarht; Gerrie Stoeken-Rijsbergen; Willem Verduyn; René R P de Vries; Jeanine J Houwing-Duistermaat; Tom W J Huizinga; Leendert A Trouw; René E M Toes
Journal:  Arthritis Rheum       Date:  2011-07

6.  Effect of interactions of glutathione S-transferase T1, M1, and P1 and HMOX1 gene promoter polymorphisms with heavy smoking on the risk of rheumatoid arthritis.

Authors:  Brendan T Keenan; Lori B Chibnik; Jing Cui; Bo Ding; Leonid Padyukov; Henrik Kallberg; Camilla Bengtsson; Lars Klareskog; Lars Alfredsson; Elizabeth W Karlson
Journal:  Arthritis Rheum       Date:  2010-11

7.  Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke.

Authors:  Henrik Källberg; Bo Ding; Leonid Padyukov; Camilla Bengtsson; Johan Rönnelid; Lars Klareskog; Lars Alfredsson
Journal:  Ann Rheum Dis       Date:  2010-12-13       Impact factor: 19.103

Review 8.  Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.

Authors:  Péter Szodoray; Zoltán Szabó; Anikó Kapitány; Agnes Gyetvai; Gabriella Lakos; Sándor Szántó; Gabriella Szücs; Zoltán Szekanecz
Journal:  Autoimmun Rev       Date:  2009-05-07       Impact factor: 9.754

9.  Socioeconomic and occupational risk factors for rheumatoid arthritis: a nationwide study based on hospitalizations in Sweden.

Authors:  Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Rheumatol       Date:  2008-05-01       Impact factor: 4.666

10.  Association between residences in U.S. northern latitudes and rheumatoid arthritis: A spatial analysis of the Nurses' Health Study.

Authors:  Verónica M Vieira; Jaime E Hart; Thomas F Webster; Janice Weinberg; Robin Puett; Francine Laden; Karen H Costenbader; Elizabeth W Karlson
Journal:  Environ Health Perspect       Date:  2010-03-25       Impact factor: 9.031

View more
  3 in total

1.  [Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].

Authors:  S Hense; A Luque Ramos; J Callhoff; K Albrecht; A Zink; F Hoffmann
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

2.  The Geospatial Distribution of Myositis and Its Phenotypes in the United States and Associations With Roadways: Findings From a National Myositis Patient Registry.

Authors:  Md M Hossain; Jesse Wilkerson; John A McGrath; Payam N Farhadi; Cole Brokamp; Md T F Khan; Bob Goldberg; Hermine I Brunner; Maurizio Macaluso; Frederick W Miller; Lisa G Rider
Journal:  Front Med (Lausanne)       Date:  2022-03-16

3.  Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study.

Authors:  Kaja Eriksson; Lena Nise; Anna Kats; Elin Luttropp; Anca Irinel Catrina; Johan Askling; Leif Jansson; Lars Alfredsson; Lars Klareskog; Karin Lundberg; Tülay Yucel-Lindberg
Journal:  PLoS One       Date:  2016-05-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.